You just read:

Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma UK and Celgene Using REOLYSIN® in Combination with Imnovid® or Revlimid® in Patients with Myeloma

News provided by

Oncolytics Biotech Inc.

16 Mar, 2017, 07:00 ET